Total Number | 517 | 357 |
Median age (IQR) | 29 (26–33) | 73 (69–78) |
Gender | 189 female, 328 male | 151 female, 195 male |
UK Born | 39 (7.5%) | 39 (10.9%) |
Pulmonary | 191 (36.9%) | 171 (47.9%) |
Smear Positive | 54/191 (28.3%) | 14/73 (19.2%) |
Data Available | 489 (177pulmonary) | 73 (all had pulmonary involvement) |
Symptoms at presentation (all patients) | All patients N = 489 | Pulmonary TB N = 177 | All patients N = 73 | Pulmonary TB N = 73 |
Cough N (%) | 186 (38) | 113 (63.8) | 38 (52.0) | 38 (52.0) |
Haemoptysis N (%) | 27 (5.5) | 22 (12.4) | 2 (2.7) | 2 (2.7) |
Fever N (%) | 162 (3.3) | 75 (42.4) | 18 (24.7) | 18 (24.7) |
Drenching night sweats N (%) | 129 (26.3) | 65 (36.7) | 12 (16.4) | 12 (16.4) |
Weight loss N (%) | 187 (38.2) | 102 (57.6) | 43 (58.9) | 43 (58.9) |
Dyspnoea N (%) | 24 (4.9) | 15 (8.5) | 28 (38.4) | 28 (38.4) |
Lethargy N (%) | 25 (5.1) | 7 (4.0) | 11 (15) | 11 (15) |
Reduced Appetite N (%) | 28 (5.7) | 13 (7.3) | 16 (21.9) | 16 (21.9) |
Neck Lymphadenopathy N (%) | 131 (26.8) | 7 (4.0) | 15 (20.5) | 15 (20.5) |
Pulmonary TB | Younger Patients (18–40) | Older Patients (over 65) |
Symptom duration at presenting to secondary care in days. Median (IQR) | 45 (30–90) | 90 (26.25–180) |
Time from secondary care to starting treatment in days. Median (IQR) | 2 (1–5.5) | 7 (2.25–41.5) |
Pulmonary TB | N = 137 | N = 37 |
Total time from symptom onset to starting treatment in Months. Median (IQR) | 2.0 (1–3) | 3.0 (1.5–6.5) |
Proportion starting within 2 months of symptom onset N (%) | 82 (59.9) | 13 (35.1) |
Proportion starting within 4 months of symptom onset n (%) | 119 (86.9) | 25 (67.6) |
Proportion starting more than 4 months of symptom onset n (%) | 18 (13.1) | 12 (32.4) |